ANIX - Anixa Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANIX is currently covered by 2 analysts with an average price target of $6.85. This is a potential upside of $4.13 (151.84%) from yesterday's end of day stock price of $2.72.

Anixa Biosciences's activity chart (see below) currently has 7 price targets and 17 ratings on display. The stock rating distribution of ANIX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ANIX is $7, Lowest price target is $7, average price target is $7.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 25-Mar-2025. First documented stock forecast 12-Apr-2021.

Best performing analysts who are covering ANIX - Anixa Biosciences:

Yi Chen Matthew Barcus

Currently out of the existing stock ratings of ANIX, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Yi Chen (HC WAINWRIGHT)

Buy

$4.42 (171.32%)

24 days ago
(25-Mar-2025)

0/14 (0%)

$3.85 (122.22%)

Please subscribe to see the analyst performance score

Matthew Barcus (CHARDAN CAPITAL)

Buy

$6.42 (248.84%)

2 years ago
(18-Apr-2023)

0/3 (0%)

$4.4 (95.65%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is ANIX (Anixa Biosciences) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ANIX (Anixa Biosciences) with a proven track record?

YI CHEN

Which analyst has the current lower performing score on ANIX (Anixa Biosciences) with a proven track record?

MATTHEW BARCUS

Which analyst has the most public recommendations on ANIX (Anixa Biosciences)?

Yi Chen works at HC WAINWRIGHT and has 10 price targets and 7 ratings on ANIX

Which analyst is the currently most bullish on ANIX (Anixa Biosciences)?

Matthew Barcus with highest potential upside - $6.42

Which analyst is the currently most reserved on ANIX (Anixa Biosciences)?

Yi Chen with lowest potential downside - $4.42

Anixa Biosciences in the News

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

On Wednesday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent related to Anixa Biosciences, Inc.’s (NASDAQ:ANIX) breast cancer vaccine technology. Cleveland Clinic has exclusively licensed the patent and others related to this technology to Anixa Biosciences. The patent will expand the scope of immunogenic compositions utilized...